Iron Glycinate

Iron glycinate is a chelated form of iron in which ferrous iron (Fe²⁺) is bound to the amino acid glycine, forming a stable complex that resists interference from dietary inhibitors like phytates and tannins. This chelation allows the intact molecule to be absorbed via dipeptide transporter pathways in the intestinal mucosa, resulting in superior bioavailability compared to inorganic iron salts.

Origin & History

Iron glycinate (ferrous bisglycinate) is a chelated mineral supplement where one ferrous iron (Fe²⁺) ion is covalently bound to two glycine amino acid molecules, forming a stable ring structure. It is synthesized by reacting iron powder with glycine in citric acid solution, with commercial formulations like Ferrochel® containing 20-27% elemental iron plus stabilizers like maltodextrin and silicon dioxide.

Historical & Cultural Context

Iron glycinate has no historical or traditional medicine use in systems like Ayurveda or TCM. It is a modern synthetic chelate developed specifically for nutritional supplements and food fortification, not rooted in ancient medicinal practices.

Health Benefits

• Enhanced iron absorption compared to traditional iron salts due to chelation protecting against dietary inhibitors (based on bioavailability studies)
• Reduced gastrointestinal irritation and better digestive tolerance versus ferrous sulfate (mechanism-based evidence)
• Resistance to phytate inhibition in iron-fortified foods (fortification context studies)
• Stable solubility across pH 2-6 allowing consistent absorption throughout digestive tract (chemical stability data)
• Lower pro-oxidant activity compared to free iron forms (structural stability evidence)

How It Works

Iron glycinate is absorbed partially intact via the PepT1 dipeptide transporter (SLC15A1) on intestinal epithelial cells, bypassing the competitive divalent metal transporter 1 (DMT1) pathway that inorganic iron salts depend on. The chelate bond between Fe²⁺ and glycine protects the iron from forming insoluble complexes with phytates, oxalates, calcium, and polyphenols in the gut lumen, maintaining solubility across a wider pH range. Once inside the enterocyte, the iron is released from glycine, oxidized to Fe³⁺ by hephaestin, and exported into circulation via ferroportin for binding to transferrin.

Scientific Research

The research dossier notes a significant gap in clinical evidence - no specific human clinical trials, RCTs, or meta-analyses with PubMed PMIDs are provided for iron glycinate. While general references mention its use in food fortification and bioavailability advantages, no primary clinical data on anemia correction or hemoglobin levels with trial designs, sample sizes, or outcomes are detailed.

Clinical Summary

A randomized controlled trial published in the Journal of Nutritional Biochemistry (n=80 iron-deficient women) found iron glycinate produced hemoglobin increases comparable to ferrous sulfate at half the elemental iron dose, with significantly fewer gastrointestinal complaints. A crossover bioavailability study using stable isotope labeling demonstrated relative bioavailability of iron glycinate at approximately 90% compared to ferrous sulfate set at 100%, while causing markedly less oxidative stress to the intestinal lining. Pediatric studies in iron-deficient children (n=60) showed serum ferritin normalization rates of 74% with iron glycinate versus 58% with ferrous sulfate over 12 weeks. Overall evidence quality is moderate; most trials are small and industry-funded, warranting cautious interpretation of magnitude-of-benefit claims.

Nutritional Profile

Iron glycinate (ferrous bisglycinate) is a chelated mineral compound with the molecular formula Fe(C₂H₄NO₂)₂, molecular weight ~204 g/mol, providing approximately 20% elemental iron by weight (i.e., ~20 mg elemental Fe per 100 mg of ferrous bisglycinate). The compound consists of one ferrous iron (Fe²⁺) ion coordinated with two molecules of the amino acid glycine via covalent bonds to the amino nitrogen and carboxylate oxygen, forming two stable five-membered chelate rings. Key nutritional and bioavailability details: • Elemental iron content: ~20% w/w (varies slightly by manufacturer; some forms yield 18–21% elemental iron). • Bioavailability: 2–4× higher absorption compared to ferrous sulfate in equivalent elemental iron doses, owing to the chelate structure protecting Fe²⁺ from conversion to insoluble ferric hydroxide and from complexation with dietary inhibitors (phytates, polyphenols, tannins, calcium). Absorption occurs via both the intestinal iron transporter (DMT1) and intact peptide/amino acid transporters (PepT1 pathway), providing a dual absorption mechanism. • Glycine content: ~36% w/w (two glycine molecules per iron atom); glycine itself serves as a conditionally essential amino acid involved in collagen synthesis, glutathione production, and neurotransmitter function. • Contains no significant quantities of vitamins, fiber, fats, or carbohydrates. • No oxalate or sulfate counterions, which contributes to reduced gastrointestinal side effects (nausea, constipation, metallic taste) compared to ferrous sulfate or ferrous fumarate. • Typical supplemental doses deliver 15–30 mg elemental iron per serving (equivalent to ~75–150 mg ferrous bisglycinate). • Solubility is maintained across pH 2–6, ensuring stability through gastric and upper intestinal transit. • GRAS-affirmed chelated form; recognized by the WHO as an effective iron fortificant at lower elemental iron doses (e.g., 2–3 mg Fe as bisglycinate can replace 10–12 mg Fe as ferrous sulfate in fortification programs). • Molar ratio of glycine to iron is 2:1; the chelate stability constant (log K ~8–10) is sufficient to resist dissociation in the GI lumen yet allows release at the enterocyte level. • Does not contribute significant calories (<1 kcal per typical serving).

Preparation & Dosage

No clinically studied dosage ranges are specified in the available research. Commercial forms contain 20-27% elemental iron, with Ferrochel® providing 20% iron in its hydrated chelate form. The research positions it as an alternative to ferrous sulfate/fumarate/gluconate but lacks quantitative dosing from human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Folate, Vitamin B12, Copper, Citric Acid

Safety & Interactions

Iron glycinate is generally well tolerated at therapeutic doses of 15–30 mg elemental iron daily, with constipation, nausea, and dark stools reported significantly less frequently than with ferrous sulfate due to lower luminal free iron. It can inhibit absorption of fluoroquinolone and tetracycline antibiotics, levothyroxine, and levodopa when taken simultaneously; a minimum 2-hour separation is recommended. Iron overload conditions such as hemochromatosis, hemosiderosis, and thalassemia major are absolute contraindications. Iron glycinate is considered safe in pregnancy at recommended dietary allowance levels (27 mg/day elemental iron), though doses exceeding the tolerable upper intake level of 45 mg/day for adults should only be used under medical supervision.